169. Menkes disease Clinical trials / Disease details
Clinical trials : 6 / Drugs : 6 - (DrugBank : 4) / Drug target genes : 9 - Drug target pathways : 14
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | JPRN-UMIN000005259 | 2011/03/03 | 18/03/2011 | Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with Menkes disease | Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with Menkes disease - Histidine-copper and diethyldithiocarbamate combination therapy for Menkes disease | Menkes disease | give a dose of copper-histidine and diethyldithiocarbamate | Kobe Unniversitu Graduate School of Medicine | NULL | Complete: follow-up complete | Not applicable | Not applicable | Male and Female | 2 | Not selected | Japan |